Korro Bio Stock (NASDAQ:KRRO)


ForecastChart

Previous Close

$45.81

52W Range

$10.29 - $98.00

50D Avg

$28.29

200D Avg

$23.49

Market Cap

$465.52M

Avg Vol (3M)

$197.94K

Beta

2.89

Div Yield

-

KRRO Company Profile


Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

112

IPO Date

Oct 03, 2019

Website

KRRO Performance


TickerGate Footer Logo

Tickergate is an advanced stock research & comparison platform for informed data-driven investment decisions. 100% customizable, institutional-grade data, easy to use.

Company

AboutContact

Connect

LinkedIn

©2025 Tickergate

Tickergate does not provide financial advices and does not issue recommendations or offers to buy stocks of sell any securities. Information is provided 'as-is' and solely for informational purposes as an advice. Tickergate does not bear any responsibility or any losses or damages that may occur as a result of reliance on this data.
Start a conversation

Ask me anything about stocks, markets, or financial data.

Market Trends
Compare Stocks